Checkpoint Inhibitors as High-Grade Gliomas Treatment: State of the Art and Future Perspectives

Glioblastoma (GBM) is the most common and aggressive malignant brain tumor in adults. Despite significant efforts, no therapies have demonstrated valuable survival benefit beyond the current standard of care. Immune checkpoint inhibitors (ICI) have revolutionized the treatment landscape and improved...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Clin Med
Egile Nagusiak: Persico, Pasquale, Lorenzi, Elena, Dipasquale, Angelo, Pessina, Federico, Navarria, Pierina, Politi, Letterio S., Santoro, Armando, Simonelli, Matteo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2021
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8036455/
https://ncbi.nlm.nih.gov/pubmed/33810532
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10071367
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak